Authors
Latest:
Cutting-Edge Heart Model Predicts Changes in the Heart That Can Lead to Atrial FibrillationA paper from a pair of physicists may reveal significant new information about the causes of atrial fibrillation and help to make cardiac ablations a more effective treatment for the condition.
Latest:
Alpha-Gal (Mammalian Meat) Allergy: Implications for PharmacistsAlpha-gal, a mammalian oligosaccharide, has recently been implicated in delayed anaphylaxis reactions to mammalian meat.
Latest:
Latent Tuberculosis After the Use of EtanerceptTNF-alpha inhibitors are used to treat a number of inflammatory conditions.
Latest:
Hepatitis C TreatmentThere are now 8 FDA approved medications for HCV treatment, all of which bypass the use of interferon.
Latest:
Patients with Advanced Cancer: Update on Pain ManagementDespite advances in pain management and palliative care, intractable cancer pain remains a significant clinical, social, and financial burden in treating the oncologic population.
Latest:
Conventional and Biologic Rheumatoid Arthritis Therapies: Utilization and Cost TrendsBased on American College of Rheumatology recommendations and novel emerging treatment options, the trend of increasing biologic use for rheumatoid arthritis is expected to continue.
Latest:
A Cultural Framework Is Essential in Patient CareRecognizing that culture is a multifaceted concept can lead to more careful and thoughtful use of the term.
Latest:
Antibiotics That Aggravate Myasthenia GravisMyasthenia gravis (MG) is an autoimmune-mediated neuromuscular disease characterized by muscle weakness.
Latest:
The Role of Pharmacogenetics in Precision MedicineClinicians have long been aware that patients do not uniformly respond to medications.
Latest:
The Ins and Outs of the Internship Application ProcessAs more pharmacists graduate from pharmacy schools, landing a job has become increasingly competitive.
Latest:
Analysis Finds Children Have Elevated Kidney, Heart Risks Years After COVID-19 InfectionResearch reveals that children face significant long-term health risks, including kidney, gastrointestinal, and cardiovascular issues, after COVID-19 infection.
Latest:
Trends in First-Year Utilization Costs of HIV MedicationsHIV is of interest among many in managed care. This paper focuses on the costs and demographic characteristics associated with new HIV therapy initiators.
Latest:
Adherence to Oral Oncolytics Requires a Clinically Integrated Approach to Specialty PharmacyDespite initiatives that help patients maintain adherence, health care providers still need to leverage their collective resources and work together to overcome this tremendous hurdle in cancer care.
Latest:
More Medications Means Changes to HIV Treatment GuidelinesThe HIV treatment update includes more considerations for coinfected patients and pregnant women than the previously published 2011 guidelines.
Latest:
Improving Compounding Safety: New Regulations and Options for Institutional InsourcingWith increasing regulatory oversight for sterile compounding and a limited ability to assure the quality of compounded sterile products obtained from external sources, many hospital pharmacies are moving to insource these products.
Latest:
Insulin Pump Therapy and Continuous Glucose MonitoringInsulin pump therapy and continuous glucose monitoring systems can be invaluable tools for patients with type 1 and type 2 diabetes.
Latest:
Biosimilars and Follow-on BiologicsPharmacists must be experts on follow-on biologics (FOBs), including biosimilars, so they can provide education to health professionals about safe prescribing and use, which ultimately affects patient care.
Latest:
Persistence With Mirabegron Versus Tolterodine in Patients With Overactive BladderIn a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.
Latest:
First-Line Pharmacologic Treatment for Type 2 Diabetes: Optimizing Metformin TherapyThis article will briefly discuss some of these issues, including treatment of diabetes (focusing on the initial treatment choices) and individualization of therapy and adherence, and will introduce an extended-release metformin dosage form, Glumetza.
Latest:
Community Pharmacist Shares Adventures From Ten Days in QuarantineA community pharmacist reflects on spending time in quarantine after a positive COVID-19 test in the family.
Latest:
Risky Business: Overanticoagulation from High-Risk Antimicrobials and WarfarinWarfarin is the most commonly prescribed anticoagulant in the United States, having been indicated for the treatment and prevention of venous thromboembolism and the prevention of thromboembolic complications.
